T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans

Journal of Infectious Diseases

Volumn 218, Issue , 2018, Pages S508-S518

  Speranza, Emily ^a,b,c   Ruibal, Paula ^d   Port, Julia R ^d,e   Feng, Feng ^a,c   Burkhardt, Lia ^f   Grundhoff, Adam ^d,e   Günther, Stephan ^d,e   Oestereich, Lisa ^d,e   Hiscox, Julian A ^g,h   Connor, John H ^a,b,c   Muñoz Fontela, Csar ^d,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c Boston University   (United States)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e German Center for Infection Research   (Germany)

^f LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h AGENCY FOR SCIENCE   (Singapore)

Author keywords

Ebola virus; gene expression; T cells; T cell receptor.

Indexed keywords

T LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSCRIPTOME;

BLOOD SAMPLING; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; GENE EXPRESSION; HOMEOSTASIS; HUMAN; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS; VIRAL CLEARANCE; VIRUS REPLICATION; VIRUS SURVIVAL; CROSS-SECTIONAL STUDY; GENETICS; IMMUNOLOGY; MORTALITY; PHYSIOLOGY;

BIOMARKERS; CROSS-SECTIONAL STUDIES; HEMORRHAGIC FEVER, EBOLA; HOMEOSTASIS; HUMANS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 85057164430     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiy352     Document Type: Conference Paper

References (57)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-25.
2. Holmes EC, Dudas G, Rambaut A, Andersen KG. The evolution of Ebola virus: insights from the 2013-2016 epidemic. Nature 2016; 538:193-200.
3. McElroy AK, Akondy RS, Davis CW, et al. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 2015; 112:4719-24.
4. Sobarzo A, Stonier SW, Herbert AS, et al. Correspondence of neutralizing humoral immunity and CD4 T cell responses in long recovered Sudan virus survivors. Viruses 2016; 8:133.
5. Ruibal P, Oestereich L, Ludtke A, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature 2016; 533:100-4.
6. Cimini E, Viola D, Cabeza-Cabrerizo M, et al. Different features of V2 T and NK cells in fatal and non-fatal human Ebola infections. PLoS Negl Trop Dis 2017; 11:e0005645.
7. Vernet MA, Reynard S, Fizet A, et al. Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. JCI Insight 2017; 2:e88864.
8. Moyen N, Thirion L, Emmerich P, et al. Risk factors associated with Ebola and Marburg viruses seroprevalence in blood donors in the Republic of Congo. PLoS Negl Trop Dis 2015; 9:e0003833.
9. Becquart P, Wauquier N, Mahlakoiv T, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010; 5:e9126.
10. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
11. Lanini S, Portella G, Vairo F, et al. Blood kinetics of Ebola virus in survivors and nonsurvivors. J Clin Invest 2015; 125:4692-8.
12. de La Vega MA, Caleo G, Audet J, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J Clin Invest 2015; 125:4421-8.
13. Liu X, Speranza E, Munoz-Fontela C, et al. Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus. Genome Biol 2017; 18:4.
14. Apasov S, Redegeld F, Sitkovsky M. Cell-mediated cytotoxicity: contact and secreted factors. Curr Opin Immunol 1993; 5:404-10.
15. Guermonprez P, Helft J, Claser C, et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 2013; 19:730-8.
16. Mellor AL, Lemos H, Huang L. Indoleamine 2, 3-dioxygenase and tolerance: where are we now Front Immunol 2017; 8:1360.
17. Durrant DM, Daniels BP, Pasieka T, Dorsey D, Klein RS. CCR5 limits cortical viral loads during West Nile virus infection of the central nervous system. J Neuroinflammation 2015; 12:233.
18. Gustavsson L, Skovbjerg S, Lindh M, Westin J, Andersson LM. Low serum levels of CCL5 are associated with longer duration of viral shedding in norovirus infection. J Clin Virol 2015; 69:133-7.
19. Rott LS, Rose JR, Bass D, Williams MB, Greenberg HB, Butcher EC. Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest 1997; 100:1204-8.
20. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527-38.
21. Danilova E, Skrindo I, Gran E, et al. A role for CCL28-CCR3 in T-cell homing to the human upper airway mucosa. Mucosal Immunol 2015; 8:107-14.
22. Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol 2015; 27:11-20.
23. Baumgartner CK, Malherbe LP. Antigen-driven T-cell repertoire selection during adaptive immune responses. Immunol Cell Biol 2011; 89:54-9.
24. Davenport MP, Price DA, McMichael AJ. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr Opin Immunol 2007; 19:294-300.
25. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 2008; 8:512-22.
26. Turner SJ, Diaz G, Cross R, Doherty PC. Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity 2003; 18:549-59.
27. Liu J, Cao S, Peppers G, Kim SH, Graham BS. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses. Eur J Immunol 2014; 44:1058-68.
28. Dahlke C, Lunemann S, Kasonta R, et al. Comprehensive characterization of cellular immune responses following Ebola virus infection. J Infect Dis 2016; 215:287-92.
29. Ludtke A, Ruibal P, Becker-Ziaja B, et al. Ebola virus disease is characterized by poor activation and reduced levels of circulating CD16+ monocytes. J Infect Dis 2016; 214(Suppl 3):S275-80.
30. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 2003; 170:2797-801.
31. Bosio CM, Aman MJ, Grogan C, et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 2003; 188:1630-8.
32. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999; 5:423-6.
33. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010; 4: pii: e837.
34. Caballero IS, Honko AN, Gire SK, et al. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genomics 2016; 17:707.
35. Connor JH, Yen J, Caballero IS, et al. Transcriptional profiling of the immune response to Marburg virus infection. J Virol 2015; 89:9865-74.
36. Speranza E, Altamura LA, Kulcsar K, et al. Comparison of transcriptomic platforms for analysis of whole blood from Ebola-infected cynomolgus macaques. Sci Rep 2017; 7:14756.
37. Versteeg K, Menicucci AR, Woolsey C, et al. Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Sci Rep 2017; 7:9730.
38. Speranza E, Bixler SL, Altamura LA, et al. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever. Sci Transl Med 2018; 10:eaaq1016.
39. Rubins KH, Hensley LE, Wahl-Jensen V, et al. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 2007; 8:R174.
40. Ka MB, Gondois-Rey F, Capo C, et al. Imbalance of circulating monocyte subsets and PD-1 dysregulation in Q fever endocarditis: The role of IL-10 in PD-1 modulation. PLoS One 2014; 9:e107533.
41. Zhang Y, Li J, Lou J, et al. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care 2011; 15:R70.
42. Mackroth MS, Abel A, Steeg C, Schulze Zur Wiesch J, Jacobs T. Acute malaria induces PD1+CTLA4+ effector T cells with cell-extrinsic suppressor function. PLoS Pathog 2016; 12:e1005909.
43. Boutej H, Rahimian R, Thammisetty SS, Beland LC, Lalancette-Hebert M, Kriz J. Diverging mRNA and protein networks in activated microglia reveal SRSF3 suppresses translation of highly upregulated innate immune transcripts. Cell Rep 2017; 21:3220-33.
44. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 2010; 10:24-35.
45. Sckisel GD, Tietze JK, Zamora AE, et al. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function. Clin Exp Immunol 2014; 175:79-91.
46. Ghani S, Feuerer M, Doebis C, et al. T cells as pioneers: Antigen-specific T cells condition inflamed sites for high-rate antigen-non-specific effector cell recruitment. Immunology 2009; 128:e870-80.
47. Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol 2001; 166:1097-105.
48. Pozner RG, Ure AE, Jaquenod de Giusti C, et al. Junin virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling. PLoS Pathog 2010; 6:e1000847.
49. Mikhak Z, Strassner JP, Luster AD. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J Exp Med 2013; 210:1855-69.
50. Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003; 424:88-93.
51. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
52. Rivino L, Kumaran EA, Thein TL, et al. Virus-specific T lymphocytes home to the skin during natural dengue infection. Sci Transl Med 2015; 7:278ra35.
53. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371:2092-100.
54. Troy AE, Shen H. Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition. J Immunol 2003; 170:672-6.
55. Goldrath AW, Sivakumar PV, Glaccum M, et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002; 195:1515-22.
56. Min B, Foucras G, Meier-Schellersheim M, Paul WE. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc Natl Acad Sci U S A 2004; 101:3874-9.
57. Vrisekoop N, Artusa P, Monteiro JP, Mandl JN. Weakly self-reactive T-cell clones can homeostatically expand when present at low numbers. Eur J Immunol 2017; 47:68-73.